Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases

Ann Rheum Dis. 2022 Nov;81(11):e222. doi: 10.1136/annrheumdis-2020-218845. Epub 2020 Sep 7.
No abstract available

Keywords: antirheumatic agents; arthritis; biological Therapy; glucocorticoids; inflammation; rheumatoid.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • COVID-19*
  • Glucocorticoids / therapeutic use
  • Hospitalization
  • Humans
  • Physicians*
  • Registries
  • Rheumatic Diseases* / complications
  • Rheumatic Diseases* / drug therapy
  • Rheumatology*

Substances

  • Antirheumatic Agents
  • Glucocorticoids